P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA

類似資料

• TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
  著者:: Barbara Depreter, 等
  出版事項: (2020-05-01)
• Leukemic stem cells and therapy resistance in acute myeloid leukemia
  著者:: Patrick Stelmach, 等
  出版事項: (2023-02-01)
• Characterising the cell biology of leukemic stem cells in acute myeloid leukemia.
  著者:: Cornforth, TV
  出版事項: (2013)
• Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
  著者:: Craddock, C, 等
  出版事項: (2013)
• Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
  著者:: Craddock, C, 等
  出版事項: (2013)